Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Making the 53-man roster isn't the only way for an NFL player to keep his season alive. More than 1,000 players were waived or released as NFL teams trimmed their rosters from 90 players to 53 on ...

Two solid-value approaches, one well-built ETF. Our research team assigns Gold ratings to strategies that they have the most conviction will outperform their Morningstar Category average over a market ...

The Green Bay Packers today announced the dates of practices that are open to the public for the 2026 Packers Training Camp, presented by UW Health Kids. This marks Green Bay's 81st training camp, a ...

The Summer Undergraduate Research Program (SURP) is an intensive, nine-week internship for undergraduates entering the summer before their final year, semester, or quarter of study. It's designed to ...

Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Find out the direct holders, institutional holders and mutual fund holders for Recursion Pharmaceuticals, Inc. (RXRX).